News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Novo Holdings A/S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.8% stake in Disc Medicine, Inc. |
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.9% stake in Galera Therapeutics, Inc. |
| 05/26/2023 |
SC 13G/A
| Novo Holdings A/S reports a 0% stake in VectivBio Holding AG |
| 02/02/2023 |
SC 13G/A
| Novo Holdings A/S reports a 5.3% stake in VectivBio Holding AG |
| 02/02/2023 |
SC 13G/A
| Novo Holdings A/S reports a 9.8% stake in Evotec SE |
| 12/12/2022 |
SC 13G/A
| Novo Holdings A/S reports a 4% stake in Arcellx, Inc. |
| 11/28/2022 |
SC 13G/A
| Novo Holdings A/S reports a 5.7% stake in Arcellx, Inc. |
| 11/03/2022 |
SC 13G/A
| Novo Holdings A/S reports a 4.5% stake in Minerva Surgical, Inc. |
| 02/02/2022 |
SC 13G/A
| Novo Holdings A/S reports a 9.3% stake in Galera Therapeutics, Inc. |
| 11/02/2021 |
SC 13G/A
| Novo Holdings A/S reports a 5% stake in Freeline Therapeutics Holdings plc |
| 09/20/2021 |
SC 13G/A
| Novo Holdings A/S reports a 4.7% stake in Inogen, Inc. |
| 05/21/2021 |
SC 13G/A
| Novo Holdings A/S reports a 4.2% stake in Harmony Biosciences Holdings, Inc. |
| 05/03/2021 |
SC 13G/A
| Novo Holdings A/S reports a 3.7% stake in Praxis Precision Medicines, Inc. |
| 02/17/2021 |
SC 13G/A
| Novo Holdings A/S reports a 16.1% stake in Inogen, Inc. |
| 02/08/2021 |
SC 13G/A
| Novo Holdings A/S reports a 6.4% stake in Harmony Biosciences Holdings, Inc. |
| 02/08/2021 |
SC 13G/A
| Novo Holdings A/S reports a 11.9% stake in Galera Therapeutics, Inc. |
| 02/05/2021 |
SC 13G/A
| Novo Holdings A/S reports a 3.1% stake in Verona Pharma plc |
| 12/30/2020 |
SC 13G/A
| Novo Holdings A/S reports a 4.8% stake in SeaSpine Holdings Corp |
| 09/04/2020 |
SC 13G/A
| Novo A/S reports a 6.6% stake in Harmony Biosciences Holdings, Inc. |
| 08/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/16/2020 |
SC 13G/A
| Novo A/S reports a 8% stake in Entasis Therapeutics Holdings Inc. |
| 02/05/2020 |
SC 13G/A
| Novo A/S reports a 6.4% stake in SeaSpine Holdings Corp |
| 02/05/2020 |
SC 13G/A
| Novo A/S reports a 16.1% stake in Inogen, Inc. |
| 02/05/2020 |
SC 13G/A
| Novo A/S reports a 13.7% stake in Galera Therapeutics, Inc. |
| 02/05/2020 |
SC 13G/A
| Novo A/S reports a 16.4% stake in Entasis Therapeutics Holdings Inc. |
| 07/01/2019 |
SC 13G/A
| Novo A/S reports a 4.7% stake in Nabriva Therapeutics PLC |
| 02/01/2019 |
SC 13G/A
| Novo A/S reports a 7.1% stake in SeaSpine Holdings Corp |
| 02/01/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/07/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/13/2018 |
SC 13G/A
| Novo A/S reports a 4.6% stake in OrthoPediatrics Corp. |
| 10/29/2018 |
SC 13G/A
| Novo A/S reports a 0% stake in Invuity, Inc. |
| 02/06/2018 |
SC 13G/A
| Novo A/S reports a 13.3% stake in Verona Pharma plc |
| 02/02/2018 |
SC 13G/A
| Novo A/S reports a 8% stake in Invuity, Inc. |
|
|
|